Study On TCM Clinical Pathway Of Acute Bronchitis In Children

Objective:To compare and analyze the relevant data before and after the implementation of the clinical pathway of traditional Chinese medicine in children with acute bronchitis,preliminarily evaluate the implementation effect of the clinical pathway of traditional Chinese medicine,standardize the diagnosis and treatment behavior,improve the medical quality,save medical costs,and provide clinical research basis for the improvement and optimization of the clinical pathway of traditional Chinese medicine.Method: Collect children with acute bronchitis who were hospitalized in the Pediatric Department of Shandong University of Traditional Chinese Medicine Affiliated Hospital from July 2020 to June 2022.According to the Western medicine diagnostic standards and traditional Chinese medicine syndrome diagnostic standards for acute bronchitis in children,acute bronchitis cases were collected and divided into non pathway group and pathway group before and after the promotion and implementation of clinical pathway in June 2021.After multiple checks,various information was entered to ensure the accuracy of the information.A database was established and entered into an Excel spreadsheet.Statistical processing was completed using SPSS 22.0,Evaluate the compliance,variability,and efficacy of acute bronchitis cases with clinical pathways,and analyze the rationality of the connotation of the pathway.result:1.There was no statistically significant difference in sex and age between children with acute bronchitis in the pathway group and those in the non-path group;The incidence rate was higher in summer,autumn and winter;In the solar terms of incidence,the incidence rate of awn seed,summer solstice and sunstroke is higher.2.Compared with the non-path group,the average length of stay and the proportion of western medicine expenses in the path group were significantly reduced,the proportion of external treatment expenses of traditional Chinese medicine was significantly increased,and the utilization rate of traditional Chinese medicine was stable.Although there was no significant difference in the proportion of traditional Chinese medicine expenses,the proportion of the path group was slightly higher than that of the non-path group;There was no significant difference in the average hospitalization expenses,but the average hospitalization expenses of the route group were slightly lower than that of the non-path group;There was no significant difference in the proportion of auxiliary examination expenses,but the proportion of the pathway group was slightly higher than that of the non-path group;The proportion of one-time material cost in the path group is higher than that in the non-path group.3.There was no significant difference in compliance and variation rate between the path group and the non-path group.The compliance of the path group was higher than that of the non-path group,and the variation rate was lower than that of the non-path group;The difference in curative effect analysis was statistically significant.The cure rate of the pathway group was higher than that of the non-path group.4.There was no statistically significant difference in the detection rate of respiratory pathogens between the path group and the non-path group,and there was no statistically significant difference in the detection rate of respiratory pathogens between the path group and the non-path group,but the detection rate of respiratory pathogens and the detection rate of respiratory viruses in the path group were slightly higher than those in the non-path group;The use rate of antibiotics in the pathway group was slightly higher than that in the non-path group,but the difference was not statistically significant.Conclusion:1.This study concluded that the implementation of TCM clinical pathway for acute bronchitis in children can improve compliance,reduce the rate of variation,shorten the average length of stay,and reduce the cost of western medicine;The utilization rate of Chinese herbal decoction pieces is stable,the application of appropriate technologies for external treatment of Chinese medicine is improved,the characteristic advantages of Chinese medicine are given full play,and the participation rate of Chinese medicine in the treatment of diseases is improved.2.The implementation of the TCM clinical pathway for acute bronchitis has improved the laboratory related etiological tests.The clinical needs to be further analyzed and optimized to promote the rational use of antibiotics.There are uncontrollable reasons such as rising prices.The cost of auxiliary examinations and one-time materials should be reasonably controlled to further shorten the average length of stay,reduce medical costs and improve the quality of medical services.